FLUDEOXYGLUCOSE (18F) INJECTION: Sterility testing could not be performed for the affected lot
Last updated
Summary
Product
FLUDEOXYGLUCOSE (18F) INJECTION
Issue
Health products - Product quality
What to do
Consult your health care professional if you have any health concerns.
Affected products
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot |
|---|---|---|---|---|---|
| FLUDEOXYGLUCOSE (18F) INJECTION | FLUDEOXYGLUCOSE (18F) INJECTION | DIN 02412837 | Solution | 18F Fludeoxyglucose (18F-FDG) 71.8 GBq | G20231011 |
Issue
Sterility testing could not be performed for the affected lot.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Healthcare establishments
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
Winnipeg Regional Health Authority
SR061-820 Sherbrook Street, Winnipeg
MB R3A 1R9
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type III
Identification number
RA-74517
Get notified
Receive emails about new and updated recall and safety alerts.